Beacon Therapeutics

Transforming Vision, Transforming Lives

London, United Kingdom · Founded 2023 · $365.0M raised

Headquarters
London
Employees
51–200
Founded
2023
Business Model
B2B
Total Funding
$365.0M
Last Round
$75.0M Series CJan 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Beacon Therapeutics is a leading clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company uses adeno-associated virus (AAV) gene therapy to develop treatments for inherited retinal diseases including X-Linked Retinitis Pigmentosa (XLRP), dry Age-related Macular Degeneration (dAMD), and Cone Rod Dystrophy (CRD). Spun out of Syncona and the University of Oxford in 2023, Beacon raised $120M at launch and an additional $170M Series B to advance its lead candidate laru-zova through late-stage clinical trials. The company operates out of London, UK with facilities in Boston, Massachusetts and Alachua, Florida.

Summary

Beacon Therapeutics is a Biotech company based in London, United Kingdom, founded in 2023. It has raised $365.0M in total across 3 rounds, most recently a $75.0M Series C round in Jan 2026. Investors include Forbion Capital Partners, Syncona Partners and Oxford Science Enterprises.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJan 2026
$75.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Beacon Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/beacon-therapeutics"><img src="https://indexed.vc/api/badge/company/beacon-therapeutics" alt="Beacon Therapeutics on Indexed.vc" width="260" height="76" /></a>